Madison Investments, an investment advisor, released its “Madison Small Cap Fund” fourth-quarter 2024 investor letter. A copy ...

Clinical research company Medpace Holdings (NASDAQ:MEDP) in Q4 CY2024, with sales up 7.7% year on year to $536.6 million. On ...

Rhumbline Advisers lifted its position in Medpace Holdings, Inc. (NASDAQ:MEDP – Free Report) by 0.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional ...

LOS ANGELES, CA / ACCESS Newswire / February 18, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...

Equities research analysts at William Blair decreased their Q3 2025 earnings estimates for Medpace in a research report ...

Medpace Holdings Inc (NASDAQ:MEDP) reported fourth-quarter financial results after the market close on Monday. Here's a ...

Clinical research company Medpace Holdings (NASDAQ:MEDP) will be announcing earnings results tomorrow after market hours. Here’s what to expect. Medpace missed analysts’ revenue expectations ...

Good day, ladies and gentlemen, and welcome to the Medpace Fourth Quarter and Full-Year 2024 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers' ...

Narrow-moat Medpace reported mixed 2024 results. Revenue increased to $2.1 billion, up 11.8% from $1.9 billion in 2023, but the company continues to face challenges from elevated cancellation ...

Medpace expects full-year earnings to be $11.93 to $12.69 per share, with revenue in the range of $2.11 billion to $2.21 billion. This story was generated by Automated Insights ( ...

Clinical research company Medpace Holdings (NASDAQ:MEDP) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.7% year on year to $536.6 million. On the other hand, the company ...

CINCINNATI (AP) — CINCINNATI (AP) — Medpace Holdings Inc. (MEDP) on Monday reported fourth-quarter earnings of $117 million. On a per-share basis, the Cincinnati-based company said it had ...